10 recruiting, 6 completed, 6 not yet recruiting, 4 active not recruiting. 30 Phase 2, 2 Phase 1, 2 Phase 3.
Follow Alcohol Use Disorder (AUD): new trials by email Literature Review of Alcohol Use Disorder (AUD) trials Research Report on Alcohol Use Disorder (AUD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Biphasic Effect of Alcohol on Pain Alcohol (IV), Saline (0.9%, sterile, for infusion) - Alcohol Use, Chronic Low-back Pain (cLBP) | Phase 2 | Not yet recruiting | Yale University | 132 | 2027-02-01 | 2026-11-17 |
| Pregnenolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding Study Brexanolone - Alcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD) | Phase 2 | Not yet recruiting | Pharmacotherapies for Alcohol and Substance Use Disorders Alliance | 40 | 2027-01-15 | 2026-09-21 |
| OEA for Young Adults With Alcohol Use Disorder oleoylethanolamide - Alcohol Use Disorder (AUD) | Phase 2 | Not yet recruiting | Medical University of South Carolina | 42 | 2027-01-15 | 2026-11-17 |
| Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving Cannabidiol (CBD), Placebo - Alcohol Use Disorder (AUD), Withdrawal From Addictive Substance; Detoxification | Phase 2 / Phase 3 | Recruiting | Johns Hopkins University | 105 | 2026-10-21 | 2026-11-03 |
| Pregnenolone Treatment for Alcohol Use Disorder and Major Depressive Disorder Pregnenolone, Placebo - Alcohol Use Disorder (AUD), Major Depressive Disorder (MDD) | Phase 2 | Not yet recruiting | Sherwood Brown, MD, PhD | 100 | 2026-10-01 | 2026-08-24 |
| Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder Psilocybin 25 mg, Placebo - Major Depressive Disorder (MDD), Alcohol Use Disorder (AUD) | Phase 2 | Recruiting | Centre for Addiction and Mental Health | 30 | 2026-03-23 | 2026-10-26 |
| Probenecid Administration for Alcohol Craving and Consumption Probenecid Oral Tablet, Placebo Oral Tablet - Alcohol Use Disorder (AUD), Alcohol Consumption | Phase 2 | Recruiting | Brown University | 120 | 2026-03-14 | 2026-03-17 |
| LSD Treatment for Persons With Alcohol Use Disorder LSD, Active placebo - Alcohol Use Disorder (AUD) | Phase 2 | Recruiting | Felix Mueller | 128 | 2026-01-27 | 2026-10-07 |
| Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide semaglutide - Alcohol Use Disorder (AUD), HIV | Phase 2 | Recruiting | Yale University | 30 | 2026-01-15 | 2026-03-24 |
| Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB) Tirzepatide, Take Control CBT Module, Placebo - Alcohol Use Disorder (AUD), Overweight or Obese | Phase 2 | Not yet recruiting | South West Sydney Local Health District | 46 | 2026-01-15 | 2025-12-18 |
| Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL) Ketamine, Cognitive Behavioural Therapy - Alcohol Use Disorder (AUD), Major Depressive Disorder (MDD) | Phase 1 / Phase 2 | Not yet recruiting | South West Sydney Local Health District | 20 | 2025-12-10 | 2025-11-25 |
| Study of Tirzepatide for Recovery and Alcohol Use Management Tirzepatide, Saline Placebo - Alcohol Use Disorder (AUD) | Phase 2 | Recruiting | Brigham and Women's Hospital | 20 | 2025-09-15 | 2026-07-09 |
| Suvorexant for Treatment of AUD and PTSD Suvorexant, Placebo - Alcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD) | Phase 2 | Recruiting | Pharmacotherapies for Alcohol and Substance Use Disorders Alliance | 76 | 2025-07-16 | 2026-10-14 |
| PsiloStudy: Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD) Psilocybin 25 mg, Maltodextrin (Placebo) - Alcohol Use Disorder (AUD), PTSD | Phase 2 | Active not recruiting | Nathan Brashares Sackett | 40 | 2025-06-01 | 2026-08-13 |
| Ketamine and Neurofeedback as Combined Therapeutic Interventions to Target Glutamatergic Neurotransmission in Alcohol Use Disorder Ketamine, Real-time fMRI Neurofeedback Training, Placebo - Alcohol Abuse/Dependence, Alcohol Use Disorder (AUD) | Phase 2 | Recruiting | Dr. med. Marcus Herdener | 75 | 2025-06-01 | 2025-12-05 |
| RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight Pemvidutide, Placebo - Alcohol Use Disorder (AUD) | Phase 2 | Completed | Altimmune, Inc. | 100 | 2025-05-15 | 2026-07-31 |
| Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms Siemens 3T PRISMA MR Scanner, PET/CT Scanner, Suvorexant - Healthy Volunteers, Alcohol Use Disorder (AUD) | Phase 1 / Phase 2 | Recruiting | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 180 | 2024-11-21 | 2026-10-19 |
| A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Alcohol Use Disorder TMP-301, Placebo - Alcohol Use Disorder (AUD) | Phase 2 | Terminated | Tempero Bio, Inc. | 110 | 2024-11-14 | 2026-04-13 |
| Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study Psilocybin - Alcohol Use Disorder (AUD) | Phase 2 | Unknown | Anders Fink-Jensen, MD, DMSci | 10 | 2023-02-09 | 2024-07-12 |
| Ibudilast for Treating Alcohol Use Disorder Ibudilast, Medical management, Placebo - Alcohol Use Disorder (AUD), Alcoholism | Phase 2 | Active not recruiting | University of Pennsylvania | 50 | 2023-01-14 | 2026-06-03 |
Showing 20 of 30. Sign in to see all of them.
Alcoholism (30) · Alcohol Drinking (5) · Substance-Related Disorders (5) · Stress Disorders, Post-Traumatic (4) · Depressive Disorder, Major (3) · Obesity (2) · Overweight (2) · Alcohol Abstinence (1) · Alcohol-Related Disorders (1) · Anxiety Disorders (1) · Behavior, Addictive (1) · Depression (1) · Mental Disorders (1) · Sleep Initiation and Maintenance Disorders (1) · Tobacco Use Disorder (1)
Chemically-Induced Disorders (30) · Alcohol-Related Disorders (29) · Mental Disorders (29) · Substance-Related Disorders (25) · Behavior (8) · Drinking Behavior (6) · Stress Disorders, Traumatic (4) · Trauma and Stressor Related Disorders (4) · Depressive Disorder (3) · Mood Disorders (3) · Body Weight (2) · Nutrition Disorders (2) · Nutritional and Metabolic Diseases (2) · Overnutrition (2) · Pathological Conditions, Signs and Symptoms (2)
Psilocybin (3) · suvorexant (3) · Cannabidiol (2) · Cognitive Behavioral Therapy (2) · Ketamine (2) · Practice Management, Medical (2) · Tirzepatide (2) · ASP8062 (1) · Acetylcysteine (1) · Doxazosin (1) · Ethanol (1) · Fluorodeoxyglucose F18 (1) · Lysergic Acid Diethylamide (1) · Orexin Receptor Antagonists (1) · Pregnenolone (1)
South West Sydney Local Health District (3) · University of Pennsylvania (3) · Brown University (2) · Medical University of South Carolina (2) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) (2) · Pharmacotherapies for Alcohol and Substance Use Disorders Alliance (2) · Washington State University (2) · Yale University (2) · Altimmune, Inc. (1) · Anders Fink-Jensen, MD, DMSci (1) · Brigham and Women's Hospital (1) · Centre for Addiction and Mental Health (1) · Dr. med. Marcus Herdener (1) · Felix Mueller (1) · Johns Hopkins University (1)
United States (22) · Australia (3) · Switzerland (2) · Canada (1) · Denmark (1)
Anders Fink-Jensen, Professor (1) · Barbara J. Mason, Ph.D. (1) · Carolina Haass-Koffler, PharmD, PhD (1) · Carolina L Haass-Koffler, PHARMD, PHD (1) · Corinde E Wiers, Ph.D. (1) · David Woliinsky, MD (1) · E. Jennifer Edelman, MD, MHS (1) · Henry R Kranzler, M.D. (1) · Henry R Kranzler, MD (1) · Ismene L. Petrakis, M.D. (1) · Joao P. De Aquino, M.D. (1) · Joji Suzuki, MD (1) · Judith Prochaska, PhD (1) · Lara Ray, PhD (1) · MacKenzie R. Peltier, Ph.D. (1)
PMID 26037245, PMID 28551590, PMID 34049101, PMID 35229945, PMID 36813084, PMID 39252861, PMID 40018886, PMID 40445294, PMID 40548528, PMID 41630040, PMID 42035882
P01AA029545 (1), P60AA006420 (1), R01AA023192 (1), R01AA032917 (1), R01AA033156 (1)